DR. REDDY'S LABORATORIES-ADR (RDY) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:RDY - US2561352038 - ADR
13.91 USD
+0.01 (+0.07%)
13.91 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 57% to RDY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.04. This target is 8.09% above the current price.
RDY was analyzed by 45 analysts. The buy percentage consensus is at 57. So analysts seem to be rather neutral about RDY.
In the previous month the buy percentage consensus was at a similar level.
RDY was analyzed by 45 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-05 | HSBC | Upgrade | Hold -> Buy |
| 2024-11-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-30 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-29 | Barclays | Maintains | Overweight -> Overweight |
| 2023-06-01 | Barclays | Maintains | Overweight -> Overweight |
| 2022-10-31 | Barclays | Maintains | Overweight |
| 2022-10-25 | Barclays | Maintains | Overweight |
| 2022-09-12 | Barclays | Maintains | Overweight |
| 2022-07-25 | Barclays | Maintains | Overweight |
| 2022-05-24 | Barclays | Maintains | Overweight |
| 2021-11-01 | Barclays | Maintains | Overweight |
| 2021-07-28 | Prabhudas Lilladher | Maintains | Accumulate |
| 2021-07-28 | Axis Direct | Maintains | Buy |
| 2021-07-28 | ICICI Securities Limited | Maintains | Hold |
| 2021-07-28 | Motilal Oswal | Maintains | Neutral |
| 2021-07-27 | Axis Direct | Maintains | Buy |
| 2021-06-23 | Axis Direct | Maintains | Buy |
| 2021-05-19 | Geojit BNP Paribas | Maintains | Buy |
| 2021-05-17 | Axis Direct | Maintains | Buy |
| 2021-05-17 | HDFC Securities | Maintains | Accumulate |
| 2021-05-17 | SMC online | Maintains | |
| 2021-05-15 | Prabhudas Lilladher | Maintains | Accumulate |
| 2021-05-15 | ICICI Securities Limited | Maintains | Hold |
| 2021-05-15 | Motilal Oswal | Maintains | Neutral |
| 2021-04-13 | Axis Direct | Maintains | Buy |
| 2021-03-10 | Nirmal Bang | Maintains | Buy |
| 2021-03-10 | Nirmal Bang Institutional | Maintains | Buy |
DR. REDDY'S LABORATORIES-ADR / RDY FAQ
What is the average price target for DR. REDDY'S LABORATORIES-ADR (RDY) stock?
45 analysts have analysed RDY and the average price target is 15.04 USD. This implies a price increase of 8.09% is expected in the next year compared to the current price of 13.91.
How do analysts rate DR. REDDY'S LABORATORIES-ADR (RDY)?
The consensus rating for DR. REDDY'S LABORATORIES-ADR (RDY) is 57.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.